{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T16:40:39Z","timestamp":1792773639090,"version":"4.5.0"},"reference-count":71,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2027,2,1]],"date-time":"2027-02-01T00:00:00Z","timestamp":1801440000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2027,2,1]],"date-time":"2027-02-01T00:00:00Z","timestamp":1801440000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T00:00:00Z","timestamp":1773273600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002865","name":"Chongqing Science and Technology Commission","doi-asserted-by":"publisher","award":["CSTB2025KJCBPJ-KPZPYB5X0023"],"award-info":[{"award-number":["CSTB2025KJCBPJ-KPZPYB5X0023"]}],"id":[{"id":"10.13039\/501100002865","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012669","name":"Natural Science Foundation Project of Chongqing","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012669","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011933","name":"Chongqing Science and Technology Foundation","doi-asserted-by":"publisher","award":["CSTB2024NSCQ-MSX0340"],"award-info":[{"award-number":["CSTB2024NSCQ-MSX0340"]}],"id":[{"id":"10.13039\/501100011933","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Genes & Diseases"],"published-print":{"date-parts":[[2027,2]]},"DOI":"10.1016\/j.gendis.2026.102148","type":"journal-article","created":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T16:51:45Z","timestamp":1773939105000},"page":"102148","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Echinocystic acid inhibits the growth of human bladder cancer cells by suppressing AKT1\/GSK\u03b2\/\u03b2-Catenin signaling and synergizes with gemcitabine"],"prefix":"10.1016","volume":"14","author":[{"given":"Xueqian","family":"Han","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liping","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziyun","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yajun","family":"Hou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunfeng","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liqiong","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1222-1735","authenticated-orcid":false,"given":"Jinyong","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.gendis.2026.102148_bib1","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J Clin"},{"issue":"9","key":"10.1016\/j.gendis.2026.102148_bib2","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1016\/j.ccell.2022.08.010","article-title":"Acquired semi-squamatization during chemotherapy suggests differentiation as a therapeutic strategy for bladder cancer","volume":"40","author":"Wang","year":"2022","journal-title":"Cancer Cell"},{"key":"10.1016\/j.gendis.2026.102148_bib3","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.ejmech.2013.03.041","article-title":"Elucidation of the pharmacophore of echinocystic acid, a new lead for blocking HCV entry","volume":"64","author":"Wang","year":"2013","journal-title":"Eur J Med Chem"},{"issue":"3","key":"10.1016\/j.gendis.2026.102148_bib4","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.bcp.2012.04.020","article-title":"Echinocystic acid ameliorates lung inflammation in mice and alveolar macrophages by inhibiting the binding of LPS to TLR4 in NF-\u03baB and MAPK pathways","volume":"84","author":"Joh","year":"2012","journal-title":"Biochem Pharmacol"},{"issue":"8","key":"10.1016\/j.gendis.2026.102148_bib5","doi-asserted-by":"crossref","first-page":"3617","DOI":"10.1002\/ptr.7839","article-title":"Echinocystic acid prevents obesity and fatty liver via interacting with FABP1","volume":"37","author":"Xiao","year":"2023","journal-title":"Phytother Res"},{"issue":"11","key":"10.1016\/j.gendis.2026.102148_bib6","doi-asserted-by":"crossref","first-page":"1963","DOI":"10.1007\/s12272-015-0599-2","article-title":"Constituents of the aerial parts of Eclipta prostrata and their cytotoxicity on human ovarian cancer cells in vitro","volume":"38","author":"Kim","year":"2015","journal-title":"Arch Pharm Res (Seoul)"},{"issue":"1","key":"10.1016\/j.gendis.2026.102148_bib7","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.canlet.2004.03.035","article-title":"Echinocystic acid induces apoptosis in HL-60 cells through mitochondria-mediated death pathway","volume":"212","author":"Tong","year":"2004","journal-title":"Cancer Lett"},{"issue":"6","key":"10.1016\/j.gendis.2026.102148_bib8","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1007\/s12032-023-02029-2","article-title":"Echinocystic acid induces the apoptosis, and inhibits the migration and invasion of non-small cell lung cancer cells","volume":"40","author":"Zhu","year":"2023","journal-title":"Med Oncol"},{"issue":"3","key":"10.1016\/j.gendis.2026.102148_bib9","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.bbrc.2004.07.004","article-title":"Molecular mechanisms of echinocystic acid-induced apoptosis in HepG2 cells","volume":"321","author":"Tong","year":"2004","journal-title":"Biochem Biophys Res Commun"},{"issue":"W1","key":"10.1016\/j.gendis.2026.102148_bib10","doi-asserted-by":"crossref","first-page":"W356","DOI":"10.1093\/nar\/gkx374","article-title":"PharmMapper 2017 update: a web server for potential drug target identification with a comprehensive target pharmacophore database","volume":"45","author":"Wang","year":"2017","journal-title":"Nucleic Acids Res"},{"issue":"Web Server issue","key":"10.1016\/j.gendis.2026.102148_bib11","doi-asserted-by":"crossref","first-page":"W32","DOI":"10.1093\/nar\/gku293","article-title":"SwissTargetPrediction: a web server for target prediction of bioactive small molecules","volume":"42","author":"Gfeller","year":"2014","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.gendis.2026.102148_bib12","doi-asserted-by":"crossref","first-page":"baq020","DOI":"10.1093\/database\/baq020","article-title":"GeneCards Version 3: the human gene integrator","volume":"2010","author":"Safran","year":"2010","journal-title":"Database"},{"issue":"1","key":"10.1016\/j.gendis.2026.102148_bib13","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1093\/nar\/30.1.412","article-title":"TTD: therapeutic target database","volume":"30","author":"Chen","year":"2002","journal-title":"Nucleic Acids Res"},{"issue":"5","key":"10.1016\/j.gendis.2026.102148_bib14","doi-asserted-by":"crossref","DOI":"10.1186\/gb-2003-4-5-p3","article-title":"DAVID: database for annotation, visualization, and integrated discovery","volume":"4","author":"Dennis","year":"2003","journal-title":"Genome Biol"},{"issue":"11","key":"10.1016\/j.gendis.2026.102148_bib15","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0294236","article-title":"SRplot: a free online platform for data visualization and graphing","volume":"18","author":"Tang","year":"2023","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.gendis.2026.102148_bib16","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1093\/nar\/gkg034","article-title":"STRING: a database of predicted functional associations between proteins","volume":"31","author":"von Mering","year":"2003","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"10.1016\/j.gendis.2026.102148_bib17","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1093\/nar\/28.1.235","article-title":"The protein data bank","volume":"28","author":"Berman","year":"2000","journal-title":"Nucleic Acids Res"},{"issue":"23\u201324","key":"10.1016\/j.gendis.2026.102148_bib18","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1016\/j.drudis.2010.10.003","article-title":"PubChem as a public resource for drug discovery","volume":"15","author":"Li","year":"2010","journal-title":"Drug Discov Today"},{"issue":"43","key":"10.1016\/j.gendis.2026.102148_bib19","doi-asserted-by":"crossref","first-page":"9954","DOI":"10.1021\/jp003020w","article-title":"Structure and dynamics of the TIP3P, SPC, and SPC\/E water models at 298 K","volume":"105","author":"Mark","year":"2001","journal-title":"J Phys Chem A"},{"issue":"8","key":"10.1016\/j.gendis.2026.102148_bib20","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1016\/j.tcb.2023.10.007","article-title":"Cancer takes many paths through G1\/S","volume":"34","author":"Knudsen","year":"2024","journal-title":"Trends Cell Biol"},{"issue":"20","key":"10.1016\/j.gendis.2026.102148_bib21","doi-asserted-by":"crossref","first-page":"2192","DOI":"10.1101\/gad.225334.113","article-title":"Epithelial-mesenchymal plasticity in carcinoma metastasis","volume":"27","author":"Tsai","year":"2013","journal-title":"Genes Dev"},{"issue":"24","key":"10.1016\/j.gendis.2026.102148_bib22","doi-asserted-by":"crossref","DOI":"10.3390\/ijms252413691","article-title":"The complex role of matrix metalloproteinase-2 (MMP-2) in health and disease","volume":"25","author":"Wolosowicz","year":"2024","journal-title":"Int J Mol Sci"},{"issue":"D1","key":"10.1016\/j.gendis.2026.102148_bib23","doi-asserted-by":"crossref","first-page":"D1670","DOI":"10.1093\/nar\/gkae973","article-title":"Generic Diagramming Platform (GDP): a comprehensive database of high-quality biomedical graphics","volume":"53","author":"Jiang","year":"2025","journal-title":"Nucleic Acids Res"},{"issue":"5","key":"10.1016\/j.gendis.2026.102148_bib24","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1016\/j.cell.2012.03.042","article-title":"Ferroptosis: an iron-dependent form of nonapoptotic cell death","volume":"149","author":"Dixon","year":"2012","journal-title":"Cell"},{"key":"10.1016\/j.gendis.2026.102148_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.critrevonc.2025.104674","article-title":"Exploring the molecular interactions between ferroptosis and the Wnt\/\u03b2-catenin signaling pathway: implications for cancer and disease therapy","volume":"210","author":"Jia","year":"2025","journal-title":"Crit Rev Oncol"},{"issue":"3","key":"10.1016\/j.gendis.2026.102148_bib26","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1021\/acs.jnatprod.9b01285","article-title":"Natural products as sources of new drugs over the nearly four decades from 01\/1981 to 09\/2019","volume":"83","author":"Newman","year":"2020","journal-title":"J Nat Prod"},{"issue":"5","key":"10.1016\/j.gendis.2026.102148_bib27","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.3390\/cells9051213","article-title":"Putting the brakes on tumorigenesis with natural products of plant origin: insights into the molecular mechanisms of actions and immune targets for bladder cancer treatment","volume":"9","author":"Wu","year":"2020","journal-title":"Cells"},{"issue":"19\u201320","key":"10.1016\/j.gendis.2026.102148_bib28","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1016\/j.drudis.2008.07.004","article-title":"Natural products in drug discovery","volume":"13","author":"Harvey","year":"2008","journal-title":"Drug Discov Today"},{"issue":"1","key":"10.1016\/j.gendis.2026.102148_bib29","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.jphs.2016.02.006","article-title":"Eclalbasaponin II induces autophagic and apoptotic cell death in human ovarian cancer cells","volume":"132","author":"Cho","year":"2016","journal-title":"J Pharmacol Sci"},{"issue":"12","key":"10.1016\/j.gendis.2026.102148_bib30","first-page":"23482","article-title":"Cyclin D1 expression is associated with stage, grade and survival in urinary bladder carcinoma","volume":"9","author":"Khabaz","year":"2016","journal-title":"Int J Clin Exp Med"},{"issue":"5","key":"10.1016\/j.gendis.2026.102148_bib31","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1007\/s40265-015-0379-9","article-title":"Palbociclib: first global approval","volume":"75","author":"Dhillon","year":"2015","journal-title":"Drugs"},{"issue":"7","key":"10.1016\/j.gendis.2026.102148_bib32","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1007\/s40265-021-01508-y","article-title":"Trilaciclib: first approval","volume":"81","author":"Dhillon","year":"2021","journal-title":"Drugs"},{"issue":"5","key":"10.1016\/j.gendis.2026.102148_bib33","doi-asserted-by":"crossref","first-page":"5981","DOI":"10.3390\/molecules19055981","article-title":"Fucoidan inhibits the proliferation of human urinary bladder cancer T24 cells by blocking cell cycle progression and inducing apoptosis","volume":"19","author":"Park","year":"2014","journal-title":"Molecules"},{"issue":"1\u20133","key":"10.1016\/j.gendis.2026.102148_bib34","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejphar.2011.04.021","article-title":"Induction of G1 cell cycle arrest and apoptosis by berberine in bladder cancer cells","volume":"661","author":"Yan","year":"2011","journal-title":"Eur J Pharmacol"},{"issue":"5","key":"10.1016\/j.gendis.2026.102148_bib35","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1016\/j.juro.2016.12.090","article-title":"Intravesical therapy for the treatment of nonmuscle invasive bladder cancer: a systematic review and meta-analysis","volume":"197","author":"Chou","year":"2017","journal-title":"J Urol"},{"issue":"2","key":"10.1016\/j.gendis.2026.102148_bib36","doi-asserted-by":"crossref","first-page":"297","DOI":"10.3390\/ijms20020297","article-title":"Epigenetic mechanisms influencing epithelial to mesenchymal transition in bladder cancer","volume":"20","author":"Monteiro-Reis","year":"2019","journal-title":"Int J Mol Sci"},{"issue":"1","key":"10.1016\/j.gendis.2026.102148_bib37","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1111\/jcmm.14767","article-title":"An EMT-related gene signature for the prognosis of human bladder cancer","volume":"24","author":"Cao","year":"2020","journal-title":"J Cell Mol Med"},{"issue":"4","key":"10.1016\/j.gendis.2026.102148_bib38","first-page":"312","article-title":"Effect of Radix notoginseng saponins on platelet activating molecule expression and aggregation in patients with blood hyperviscosity syndrome","volume":"24","author":"Wang","year":"2004","journal-title":"Zhongguo Zhong Xi Yi Jie He Za Zhi"},{"issue":"1","key":"10.1016\/j.gendis.2026.102148_bib39","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1146\/annurev-pathmechdis-051222-115023","article-title":"Apoptosis in cancer biology and therapy","volume":"20","author":"Moyer","year":"2025","journal-title":"Annu Rev Pathol"},{"issue":"11","key":"10.1016\/j.gendis.2026.102148_bib40","first-page":"1262","article-title":"Ellagic acid induces apoptosis in TSGH8301 human bladder cancer cells through the endoplasmic reticulum stress- and mitochondria-dependent signaling pathways","volume":"29","author":"Ho","year":"2014","journal-title":"Environ Toxicol"},{"issue":"9","key":"10.1016\/j.gendis.2026.102148_bib41","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1002\/mc.22154","article-title":"Kaempferol suppresses bladder cancer tumor growth by inhibiting cell proliferation and inducing apoptosis","volume":"54","author":"Dang","year":"2015","journal-title":"Mol Carcinog"},{"issue":"5\u20136","key":"10.1016\/j.gendis.2026.102148_bib42","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.phrs.2008.09.005","article-title":"(-)Gossypol promotes the apoptosis of bladder cancer cells in vitro","volume":"58","author":"Macoska","year":"2008","journal-title":"Pharmacol Res"},{"issue":"10","key":"10.1016\/j.gendis.2026.102148_bib43","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1002\/cac2.12602","article-title":"FGFR3 alterations in bladder cancer: sensitivity and resistance to targeted therapies","volume":"44","author":"Noeraparast","year":"2024","journal-title":"Cancer Commun"},{"issue":"4","key":"10.1016\/j.gendis.2026.102148_bib44","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/j.jhep.2017.05.014","article-title":"Histological subtypes of hepatocellular carcinoma are related to gene mutations and molecular tumour classification","volume":"67","author":"Calderaro","year":"2017","journal-title":"J Hepatol"},{"issue":"4","key":"10.1016\/j.gendis.2026.102148_bib45","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1016\/j.jtho.2016.12.014","article-title":"Driven by mutations: the predictive value of mutation subtype in EGFR-mutated non-small cell lung cancer","volume":"12","author":"Castellanos","year":"2017","journal-title":"J Thorac Oncol"},{"issue":"7","key":"10.1016\/j.gendis.2026.102148_bib46","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1038\/leu.2014.94","article-title":"Chromatin modifiers and the promise of epigenetic therapy in acute leukemia","volume":"28","author":"Greenblatt","year":"2014","journal-title":"Leukemia"},{"key":"10.1016\/j.gendis.2026.102148_bib47","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2023.155253","article-title":"Natural products for gastric carcinoma prevention and treatment: focus on their antioxidant stress actions in the Correa's cascade","volume":"123","author":"Guo","year":"2024","journal-title":"Phytomedicine"},{"issue":"8","key":"10.1016\/j.gendis.2026.102148_bib48","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1002\/cncr.31978","article-title":"Targeting autophagy using natural compounds for cancer prevention and therapy","volume":"125","author":"Deng","year":"2019","journal-title":"Cancer"},{"issue":"22","key":"10.1016\/j.gendis.2026.102148_bib49","doi-asserted-by":"crossref","first-page":"5656","DOI":"10.1039\/D4BM01023J","article-title":"Pyroptosis induced by natural products and their derivatives for cancer therapy","volume":"12","author":"Wen","year":"2024","journal-title":"Biomater Sci"},{"issue":"6","key":"10.1016\/j.gendis.2026.102148_bib50","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1038\/s41580-024-00703-5","article-title":"The cell biology of ferroptosis","volume":"25","author":"Dixon","year":"2024","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"5","key":"10.1016\/j.gendis.2026.102148_bib51","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1038\/s41571-020-00462-0","article-title":"Broadening horizons: the role of ferroptosis in cancer","volume":"18","author":"Chen","year":"2021","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1016\/j.gendis.2026.102148_bib52","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1038\/s41392-025-02296-7","article-title":"Acevaltrate as a novel ferroptosis inducer with dual targets of PCBP1\/2 and GPX4 in colorectal cancer","volume":"10","author":"Yu","year":"2025","journal-title":"Signal Transduct Target Ther"},{"issue":"1","key":"10.1016\/j.gendis.2026.102148_bib53","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1038\/s41392-020-0149-3","article-title":"Erianin, a novel dibenzyl compound in Dendrobium extract, inhibits lung cancer cell growth and migration via calcium\/calmodulin-dependent ferroptosis","volume":"5","author":"Chen","year":"2020","journal-title":"Signal Transduct Target Ther"},{"issue":"12","key":"10.1016\/j.gendis.2026.102148_bib54","doi-asserted-by":"crossref","first-page":"4045","DOI":"10.1016\/j.apsb.2021.03.036","article-title":"Baicalin induces ferroptosis in bladder cancer cells by downregulating FTH1","volume":"11","author":"Kong","year":"2021","journal-title":"Acta Pharm Sin B"},{"issue":"1","key":"10.1016\/j.gendis.2026.102148_bib55","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1186\/s12885-021-08687-7","article-title":"A novel survival model based on a ferroptosis-related gene signature for predicting overall survival in bladder cancer","volume":"21","author":"Liang","year":"2021","journal-title":"BMC Cancer"},{"key":"10.1016\/j.gendis.2026.102148_bib56","article-title":"Identification of a novel ferroptosis-related gene prognostic signature in bladder cancer","volume":"11","author":"Sun","year":"2021","journal-title":"Front Oncol"},{"issue":"6","key":"10.1016\/j.gendis.2026.102148_bib57","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1023\/B:APPT.0000045801.15585.dd","article-title":"PI3K-Akt pathway: its functions and alterations in human cancer","volume":"9","author":"Osaki","year":"2004","journal-title":"Apoptosis"},{"issue":"10","key":"10.1016\/j.gendis.2026.102148_bib58","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1016\/j.cellsig.2011.05.004","article-title":"Akt signalling in health and disease","volume":"23","author":"Hers","year":"2011","journal-title":"Cell Signal"},{"issue":"50","key":"10.1016\/j.gendis.2026.102148_bib59","doi-asserted-by":"crossref","first-page":"7455","DOI":"10.1038\/sj.onc.1209085","article-title":"Perturbations of the AKT signaling pathway in human cancer","volume":"24","author":"Altomare","year":"2005","journal-title":"Oncogene"},{"issue":"10","key":"10.1016\/j.gendis.2026.102148_bib60","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1016\/j.humpath.2011.10.026","article-title":"Mutations in FGFR3 and PIK3CA, singly or combined with RAS and AKT1, are associated with AKT but not with MAPK pathway activation in urothelial bladder cancer","volume":"43","author":"Juanpere","year":"2012","journal-title":"Hum Pathol"},{"issue":"8","key":"10.1016\/j.gendis.2026.102148_bib61","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1097\/CAD.0b013e3280cc2c6f","article-title":"Targeting Akt in cancer therapy","volume":"18","author":"LoPiccolo","year":"2007","journal-title":"Anticancer Drugs"},{"issue":"3","key":"10.1016\/j.gendis.2026.102148_bib62","doi-asserted-by":"crossref","first-page":"869","DOI":"10.3892\/ijo.2015.3306","article-title":"Akt inhibitors in cancer treatment: the long journey from drug discovery to clinical use","volume":"48","author":"Nitulescu","year":"2016","journal-title":"Int J Oncol"},{"issue":"Pt 2","key":"10.1016\/j.gendis.2026.102148_bib63","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/j.freeradbiomed.2022.11.003","article-title":"Taurine attenuates neuronal ferroptosis by regulating GABA(B)\/AKT\/GSK3\u03b2\/\u03b2-catenin pathway after subarachnoid hemorrhage","volume":"193","author":"Liu","year":"2022","journal-title":"Free Radic Biol Med"},{"issue":"3","key":"10.1016\/j.gendis.2026.102148_bib64","doi-asserted-by":"crossref","first-page":"2575","DOI":"10.1021\/acsomega.4c07198","article-title":"Perfluorooctanoic acid induces ferroptosis in hepatocytes via oxidative stress and AKT\/GSK3\u03b2\/\u03b2-catenin pathway disruption","volume":"10","author":"Feng","year":"2025","journal-title":"ACS Omega"},{"key":"10.1016\/j.gendis.2026.102148_bib65","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2024.1372330","article-title":"Regulation of ferroptosis by PI3K\/Akt signaling pathway: a promising therapeutic axis in cancer","volume":"12","author":"Su","year":"2024","journal-title":"Front Cell Dev Biol"},{"key":"10.1016\/j.gendis.2026.102148_bib66","doi-asserted-by":"crossref","first-page":"2672","DOI":"10.1038\/s41467-022-30217-7","article-title":"N6-methyladenosine regulated FGFR4 attenuates ferroptotic cell death in recalcitrant HER2-positive breast cancer","volume":"13","author":"Zou","year":"2022","journal-title":"Nat Commun"},{"issue":"4","key":"10.1016\/j.gendis.2026.102148_bib67","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.7150\/ijbs.83774","article-title":"UPP1 enhances bladder cancer progression and gemcitabine resistance through AKT","volume":"20","author":"Du","year":"2024","journal-title":"Int J Biol Sci"},{"issue":"9","key":"10.1016\/j.gendis.2026.102148_bib68","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1038\/s41388-020-01634-z","article-title":"KNSTRN promotes tumorigenesis and gemcitabine resistance by activating AKT in bladder cancer","volume":"40","author":"Xiong","year":"2021","journal-title":"Oncogene"},{"issue":"2","key":"10.1016\/j.gendis.2026.102148_bib69","doi-asserted-by":"crossref","first-page":"33","DOI":"10.3892\/or.2021.8244","article-title":"Berberine enhances gemcitabine-induced cytotoxicity in bladder cancer by downregulating Rad51 expression through inactivating the PI3K\/Akt pathway","volume":"47","author":"Gao","year":"2022","journal-title":"Oncol Rep"},{"issue":"19","key":"10.1016\/j.gendis.2026.102148_bib70","doi-asserted-by":"crossref","first-page":"4682","DOI":"10.3390\/cancers14194682","article-title":"Plant-derived sulforaphane suppresses growth and proliferation of drug-sensitive and drug-resistant bladder cancer cell lines in vitro","volume":"14","author":"Xie","year":"2022","journal-title":"Cancers"},{"key":"10.1016\/j.gendis.2026.102148_bib71","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1016\/j.biopha.2018.07.083","article-title":"Synergistic antitumour effects of triptolide plus gemcitabine in bladder cancer","volume":"106","author":"Yang","year":"2018","journal-title":"Biomed Pharmacother"}],"container-title":["Genes & Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352304226001200?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352304226001200?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T15:46:37Z","timestamp":1792770397000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352304226001200"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2027,2]]},"references-count":71,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2027,2]]}},"alternative-id":["S2352304226001200"],"URL":"https:\/\/doi.org\/10.1016\/j.gendis.2026.102148","relation":{},"ISSN":["2352-3042"],"issn-type":[{"value":"2352-3042","type":"print"}],"subject":[],"published":{"date-parts":[[2027,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Echinocystic acid inhibits the growth of human bladder cancer cells by suppressing AKT1\/GSK\u03b2\/\u03b2-Catenin signaling and synergizes with gemcitabine","name":"articletitle","label":"Article Title"},{"value":"Genes & Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.gendis.2026.102148","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Publishing services by Elsevier B.V. on behalf of KeAi Communications Co. Ltd.","name":"copyright","label":"Copyright"}],"article-number":"102148"}}